Mazdak A. Khalighi
No Rating Available
(Learn About Our Rating System)

Mazdak A. Khalighi, MD

Languages spoken: English

  • Dr. Mazdak Khalighi is a board certified anatomic pathologist. He completed a residency in anatomic pathology at the University of California, Los Angeles, where he also served as chief resident. He subsequently completed a fellowship in medical renal pathology at the University of Chicago, where he gained an interest in immunology and auto-reactive diseases as well as immunofluorescence and electron microscopy. He joins the immunodermatology laboratory at the University of Utah with particular interest in autoimmune disease affecting the skin and mucous membranes.

    Specialties

  • Dr. Mazdak Khalighi is a board certified anatomic pathologist. He completed a residency in anatomic pathology at the University of California, Los Angeles, where he also served as chief resident. He subsequently completed a fellowship in medical renal pathology at the University of Chicago, where he gained an interest in immunology and auto-reactive diseases as well as immunofluorescence and electron microscopy. He joins the immunodermatology laboratory at the University of Utah with particular interest in autoimmune disease affecting the skin and mucous membranes.

    Board Certification and Academic Information

    Academic Departments Dermatology -Assistant Professor (Clinical)
    Pathology -Adjunct Assistant Professor

    Education history

    Undergraduate Cellular and Molecular Biology - University of Michigan B.S.
    Professional Medical Medicine - Jefferson Medical College M.D.
    Internship Pediatrics - Stanford University Hospitals Intern
    Residency Anatomic Pathology - University of California, Los Angeles Resident
    Chief Resident Anatomic Pathology - University of California, Los Angeles Chief Resident
    Fellowship Renal Pathology - University of Chicago Fellow
    Fellowship Surgical Pathology - University of Utah School of Medicine Fellow

    Selected Publications

    Journal Article

    1. Khalighi MA, Gallan AJ, Chang A, Meehan S (2018). Collapsing Glomerulopathy in Lambda Light Chain Amyloidosis: A Report of 2 Cases. American journal of kidney diseases, 72(4), 612-616. (Read full publication)
    2. Hahn BH, McMahon MA, Wilkinson A, Wallace WD, Daikh DI, Fitzgerald JD, Karpouzas GA, Merrill JT, Wallace DJ, Yazdany J, Ramsey-Goldman R, Singh K, Khalighi M, Choi SI, Gogia M, Kafaja S, Kamgar M, Lau C, Martin WJ, Parikh S, Peng, J, Rastogi A, Chen W, Grossman J (2012). American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis care and research, 64(6), 797-808.
    3. Khalighi MA, Wang S, Henriksen KJ, Bock M, Keswani M, Chang A, Meehan S (2015). Pauci-immune glomerulonephritis in children: a clinicopathologic study of 21 patients. Pediatric nephrology (Berlin, Germany), 30(6), 953-9. (Read full publication)
    4. Mansour SG, Hall IE, Reese PP, Jia Y, Thiessen-Philbrook H, Moeckel G, Weng FL, Revelo MP, Khalighi MA, Trivedi A, Doshi MD, Schröppel B, Parikh C (2018). Reliability of deceased-donor procurement kidney biopsy images uploaded in United Network for Organ Sharing. Clinical transplantation, 32(12), e13441. (Read full publication)
    5. Lloyd IE, Ahmed F, Revelo MP, Khalighi M (2018). De novo immune complex deposition in kidney allografts: a series of 32 patients. Human pathology, 71, 109-116.
    6. Ziegler ME, Chen T, LeBlanc JF, Wei X, Gjertson DW, Li KC, Khalighi MA, Lassman CR, Veale JL, Gritsch HA, Reed E (2011). Apolipoprotein A1 and C-terminal fragment of ¿-1 antichymotrypsin are candidate plasma biomarkers associated with acute renal allograft rejection. Transplantation, 92(4), 388-95. (Read full publication)
    7. Khalighi MA, Wang S, Henriksen KJ, Bock M, Keswani M, Meehan SM, Chang (2016). Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy. Clinical kidney journal, 9(3), 397-402. (Read full publication)
    8. Lloyd IE, Gallan A, Huston HK, Raphael KL, Miller DV, Revelo MP, Khalighi M (2016). C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome. Clinical kidney journal, 9(6), 794-799. (Read full publication)
    9. Khalighi MA, Al-Rabadi L, Chalasani M, Smith M, Kakani S, Revelo MP, Meehan S (2018). Staphylococcal Infection-Related Glomerulonephritis With Cryoglobulinemic Features. Kidney international reports, 3(5), 1128-1134. (Read full publication)
    10. Leiferman KM, Snook JP, Khalighi MA, Kuechle MK, Zone J (2022). Diagnostics for Dermatologic Diseases with Autoantibodies. The journal of applied laboratory medicine, 7(1), 165-196. (Read full publication)
    11. Daines B, Madigan LM, Vitale PA, Khalighi M, Innes (2022). A new eruption of bullous pemphigoid following mRNA COVID-19 vaccination. Dermatology online journal, 28(4), (Read full publication)
    12. Stone CJ, Nicholson L, Florell SR, Khalighi MA, Lewis BK (2023). A case of secondary syphilis presenting like pemphigus with positive direct immunofluorescence. JAAD case reports, 42, 38-41. (Read full publication)

    Review

    1. Khalighi MA, Chang (2021). Infection-Related Glomerulonephritis. Glomerular diseases, 1(2), 82-91. (Read full publication)

    Case Report

    1. Jimenez A, Blain K, Khalighi M, Clarke JT, Snook J, Cipriano S (2021). Neonatal pemphigoid gestationis: An atypical presentation of a rare disease. Pediatric dermatology, 38(6), 1575-1576. (Read full publication)
    2. Kukull BJ, Khalighi MA, Gundle KR, Hansford BG, Corless CL, Davis J (2020). Low-grade Osteosarcomatous Dedifferentiation of an Atypical Lipomatous Tumor in a Pediatric Patient. Pediatric and developmental pathology, 23(3), 240-246. (Read full publication)